Skip to main content
CTNM logo

CTNM

Contineum Therapeutics, Inc.
$15.10 -0.14 (-0.92%) At close · Jul 2
Market Cap
$644.97M
Shares
37,386,377

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 90
Total Value: $430,774,451
Total Shares: 32,984,265

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 90 13F filers · Δ vs Dec 31, 2025
Top Holder
9.3%
Jun 2024 → Mar 2026 · range 9.3% – 15.8%
−0.3 pts
Top 5
36.2%
Jun 2024 → Mar 2026 · range 36.2% – 56.2%
−2.0 pts
Top 10
58.2%
Jun 2024 → Mar 2026 · range 58.2% – 78.7%
−3.1 pts
HHI
439
Jun 2024 → Mar 2026 · range 439 – 848
Broadly held−39

Quarterly Activity

vs Dec 31, 2025
New
22
Increased
30
Decreased
20
Sold Out
12
Unchanged
18
Holder count: +10
Institutional value: +27.2%
Shares held: +11.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 92 of 92
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1855175 CUSIP 21217B100 Visit website Investor relations